>> Monday
>> Tuesday
>> Wednesday
Tuesday 01 July 2025
08:30 - 09:30
Session 34: Incorporating artificial intelligence in clinical practice - are we there yet?
Tuesday 01 July 2025
08:30 - 09:30: Session 34: Incorporating artificial intelligence in clinical practice - are we there yet?:
Edgardo Somigliana, Italy
08:30 - 08:50
Implementation of Artificial Intelligence (AI) in ART and Streamlining the Workflow of Fertility Treatments using AI
09:00 - 09:20
Leveraging artificial intelligence to enhance ovarian stimulation
08:30 - 09:30
Session 35: OMICS, reproductive life-span and menopause
08:30 - 09:30: Session 35: OMICS, reproductive life-span and menopause:
Willem Verpoest, The Netherlands
Chairperson to be announced
08:30 - 08:50
Monogenic diagnostics and polygenic screening of natural age at menopause
09:00 - 09:20
Developing therapeutic strategies targeting ovarian fibrosis to extend female reproductive longevity
08:30 - 09:30
Session 36: Recurrent pregnancy loss: bridging the gap between research and treatment
08:30 - 09:30: Session 36: Recurrent pregnancy loss: bridging the gap between research and treatment:
Chairperson to be announced
Chairperson to be announced
08:30 - 08:50
Tracing the genetic threads of (recurrent) pregnancy loss
09:00 - 09:20
Tailoring treatment to ploidy: personalized approaches in (recurrent) pregnancy loss care
Rima Dhillon-Smith, United Kingdom
08:30 - 09:30
Session 37: The role of robotic surgery in reproductive medicine
08:30 - 09:30: Session 37: The role of robotic surgery in reproductive medicine:
Chairperson to be announced
08:30 - 08:50
The use of robotic surgery in the management of uterine fibroids
09:00 - 09:20
The value of robotic surgery in the management of endometriosis
08:30 - 09:30
Session 38: Debate: Commercialisation is a necessity for ART to flourish
08:30 - 09:30: Session 38: Debate: Commercialisation is a necessity for ART to flourish:
Lucy Frith, United Kingdom
Chairperson to be announced
Lucy van de Wiel, United Kingdom
Lucy van de Wiel, United Kingdom
08:30 - 09:30
Session 39: Parenting assessment and the access to reproductive medicine
08:30 - 09:30: Session 39: Parenting assessment and the access to reproductive medicine:
Chairperson to be announced
08:30 - 08:50
Child welfare assessments and the regulation of access to publicly funded fertility treatment
09:00 - 09:20
Investigating new perceptions in fertility care access in Ireland
08:30 - 09:30
Session 40: Poster discussion session
08:30 - 09:30: Session 40: Poster discussion session:
09:00 - 12:00
Practicing embryo transfer techniques using a virtual reality-based simulator
09:00 - 12:00: Practicing embryo transfer techniques using a virtual reality-based simulator:
09:00 - 09:05
Welcome – course overview
09:05 - 09:35
Current embryo transfer practice: standardizing the embryo transfer protocol
09:35 - 09:55
Embryo transfer: the role of the embryologist
09:55 - 10:15
Discussion/ Q&A
10:15 - 12:00
Hands-on simulator training
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
10:00 - 11:30
Session 41: Rapid vitirification and warming techniques
10:00 - 11:30: Session 41: Rapid vitirification and warming techniques:
Amy Barrie, United Kingdom
Moncef Benkhalifa, France
10:00 - 10:15
Validation of a rapid vitrification protocol for human blastocysts
10:15 - 10:30
Optimizing morphokinetic embryo development: oocyte and embryo vitrification and thawing via ultra-rapid warming protocol
Olena Kotliarova, Ukraine
10:30 - 10:45
Transcriptomic landscape of human oocytes and trophectoderm cells following ultra-rapid or standard vitrification
10:45 - 11:00
Ultrafast versus conventional blastocyst warming: equivalent developmental outcomes following the extended in vitro culture of 221 embryos beyond the implantation stages
11:00 - 11:15
Comparison of one-step and multi-step warming protocols: a series of 2792 blastocysts
Tutku Melis Aygün, Turkey
11:15 - 11:30
Ultra-fast vs. traditional warming: a study on human oocyte and blastocyst survival, in vitro development, and reproductive success.
10:00 - 11:30
Session 42: PCOS: from basic science to clinical translation
10:00 - 11:30: Session 42: PCOS: from basic science to clinical translation:
Ying C. Cheong, United Kingdom
Chairperson to be announced
10:00 - 10:15
Preselected for an award: A randomized controlled trial of combined letrozole and clomiphene citrate (CLC II) versus letrozole monotherapy for women with polycystic ovary syndrome (PCOS)
10:15 - 10:30
The ULTRA trial: 12-month outcomes of transvaginal ULTRAsound-guided ovarian ablation in women with PCOS-related infertility
Saad Amer, United Kingdom
10:30 - 10:45
A 37-year prospective study of polycystic ovary syndrome patients: impact of body mass index at enrolment on long-term morbidity and mortality
10:45 - 11:00
Characteristics of serum anti-mullerian hormone levels in women with polycystic ovarian syndrome (PCOS) compared to those without PCOS: a propensity score matched study
11:00 - 11:15
Dysregulated Epigenetic Reprogramming during Pre-Implantation Development of Embryos from Patients with Polycystic Ovary Syndrome
11:15 - 11:30
Validating the use of multiples of the median (MoM) of serum anti-Mullerian hormone (AMH) levels for diagnosing polycystic ovary syndrome
Raymond Hang Wun Li, Hong Kong
10:00 - 13:00
Session 43: Live surgery session
10:00 - 13:00: Session 43: Live surgery session:
María Isabel Acien, Spain
Tubal reanastomosis with robot
Adenomyomectomy with robot
Salle 2 : Laparoscopic surgery
Laparoscopic myomectomy with uterine arteries clipping
Filipa Beja Osorio, Portugal
DIE minimal invasive surgery (laparoscopy)
Michael D. Mueller, Switzerland
Aschermann and Isthmocèle
Guillaume Legendre, France
Attilio Di Spiezio Sardo, Italy
Myomectomy with 15Fr bipolar miniresectoscope
Salle 4: Hysteroscopic surgery
Endometrial polyp with shaver
Attilio Di Spiezio Sardo, Italy
10:00 - 11:30
Session 44: Oocyte maturation, competence and selection
10:00 - 11:30: Session 44: Oocyte maturation, competence and selection:
Gemma Arroyo Cardona, Spain
Chairperson to be announced
10:00 - 10:15
Oocyte morphology and embryo morphokinetics after biphasic in vitro maturation (IVM) versus monophasic IVM in subfertile patients with PCOS: a sibling oocyte study
10:15 - 10:30
Human cumulus cells-derived miRNAs and their role in the acquisition of the oocyte developmental competence
10:30 - 10:45
The optimal time identification in patients with oocyte vitrification for a better cumulative live birth rate
10:45 - 11:00
Optimizing donor cycles’ management: definition of the optimal number of warmed oocytes to balance IVF efficacy and surplus embryos.
11:00 - 11:15
Oocyte selection through artificial intelligence: A novel predictive model to support clinical decision-making and improve IVF outcomes
Mariana Vitushynska, Ukraine
11:15 - 11:30
Single-cell proteomic analysis of protein alterations in human oocytes undergoing in Vitro aging
10:00 - 11:30
Session 45: Using big data to investigate implantation and early pregnancy
10:00 - 11:30: Session 45: Using big data to investigate implantation and early pregnancy:
Chairperson to be announced
10:00 - 10:15
Biochemical or clinical pregnancy loss following the first embryo frozen transfer does not increase the risk of pregnancy loss in the subsequent embryo transfer
10:15 - 10:30
Miscarriage prevalence and factors: a multi-source approach in France
Marie-Caroline Compans, France
10:30 - 10:45
No effect of maternal age on embryo implantation and live birth rates after preimplantation genetic testing for aneuploidies: retrospective analysis of 11,855 single blastocyst transfers
10:45 - 11:00
Cumulative live birth rates of 31 478 untested embryos from 11 463 women challenge traditional RIF definitions
11:00 - 11:15
AI-driven prognosis for autologous IVF: leveraging data from 3,852 cycles across multiple centers for personalized success predictions
Núria Correa Mañas, Spain
11:15 - 11:30
Intrauterine platelet-rich plasma infusion increases biochemical/clinical pregnancy whilst decreasing miscarriage, resulting in increased live birth/ongoing pregnancy in patients suffering from recurrent implantation failure: A meta-analysis.
10:00 - 11:30
Session 46: Supporting mental health in fertility care
10:00 - 11:30: Session 46: Supporting mental health in fertility care:
Verena Ehrbar, Switzerland
Chairperson to be announced
10:00 - 10:15
Assessing the impact of a workshops series to support parental disclosure in families of donor-conceived children in Ireland
10:15 - 10:30
Understanding patient perceptions of emotional care following a failed IVF cycle: identifying gaps and support needs
Sarah Banks, United Kingdom
10:30 - 10:45
Understanding decision-making pathways for oocyte disposition among elective egg freezers
10:45 - 11:00
Pregnancy loss has significant mental health consequences, a prospective cohort study of 2,085 women and 1,212 partners
Astrid Marie Kolte, Denmark
11:00 - 11:15
Beyond medical infertility: a mixed-methods study of 2S/LGBTQIA+ couples undergoing medically assisted reproduction
Katherine Péloquin, Canada
11:15 - 11:30
The power of counseling: Reducing IVF cancellations and strengthening patient commitment
Salma Selim, United Arab Emirates
10:00 - 11:30
Session 47: Poster discussion session
10:00 - 11:30: Session 47: Poster discussion session:
11:45 - 13:05
Session 48: European and Global ART monitoring & EUMAR
11:45 - 13:05: Session 48: European and Global ART monitoring & EUMAR:
Chairperson to be announced
Chairperson to be announced
11:45 - 12:15
Assisted Reproductive Technology (ART) in Europe 2022: preliminary results generated from European registers by the ESHRE EIM consortium
Diane De Neubourg, Belgium
12:15 - 12:35
EuMAR pilot study: key findings and next steps
Carlos Calhaz-Jorge, Portugal
12:35 - 12:50
ICMART Preliminary World Report 2021
12:50 - 13:05
ICMART updates: Revision of the international glossary on infertility and fertility care and of the ICMART data collection forms
Silke J. Dyer, South Africa
11:45 - 12:45
Session 49: Zooming into embryonic cells
11:45 - 12:45: Session 49: Zooming into embryonic cells:
Chairperson to be announced
11:45 - 12:05
Studying embryos at single-cell resolution: implications for reproductive medicine
Antonio Scialdone, Germany
12:05 - 12:15
Discussiion
12:15 - 12:35
Cellular bases of cell polarity and their role in blastocyst formation
11:45 - 12:45
Session 50: Variation in infertility rates, monitoring and treatment across the globe
11:45 - 12:45: Session 50: Variation in infertility rates, monitoring and treatment across the globe:
Chairperson to be announced
11:45 - 12:05
How reproductive imaginaries shape monitoring and treatment of infertility
Jasmine Fledderjohann, United Kingdom
12:15 - 12:35
Changing reproductive behaviours and infertility
11:45 - 12:45
Session 51: Supporting patients through their fertility journey: from essential care to AI-powered solutions
11:45 - 12:45: Session 51: Supporting patients through their fertility journey: from essential care to AI-powered solutions:
Chairperson to be announced
Chairperson to be announced
11:45 - 12:00
Preselected for an award: Menstrual practices and unmet menstrual needs among women in Tehran, Iran: a cross-sectional study
12:00 - 12:15
Preselected for an award: Clinical efficacy of virtual reality for acute pain and anxiety management during transvaginal oocyte retrieval for in vitro fertilization: a randomized controlled trial.
Valerie Schutyser, Belgium
12:15 - 12:30
Preselected for an award: A mixed-methods examination of the experiences and emotional responses of oocyte donors about disclosing their donation to their family, friends, and children
12:30 - 12:45
Preselected for an award: Revolutionizing fertility nursing: AI-powered patient support with CHARLI
Samantha Costa, Australia
11:45 - 12:45
Session 52: Poster discussion session
11:45 - 12:45: Session 52: Poster discussion session:
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:15
Session 53: MHR Symposium:Basic science of ovarian function in vivo and in vitro
14:00 - 15:15: Session 53: MHR Symposium:Basic science of ovarian function in vivo and in vitro:
14:00 - 14:30
Synthetic Ex utero embryogenesis: from naive pluripotent cells to complete developmental models
Evelyn E. Telfer, United Kingdom
14:40 - 15:00
MHR Early career innovator award:Novel actions of paxillin in female reproduction and androgen excess disorders
14:00 - 15:00
Session 54: Debate: oral GnRH antagonist for endometriosis
14:00 - 15:00: Session 54: Debate: oral GnRH antagonist for endometriosis:
Carlos Calhaz-Jorge, Portugal
Chairperson to be announced
Marie-Madeleine Dolmans, Belgium
Marie-Madeleine Dolmans, Belgium
14:00 - 15:00
Session 55: Genetics cause of male infertility : where are we in 2025?
14:00 - 15:00: Session 55: Genetics cause of male infertility : where are we in 2025?:
Chairperson to be announced
14:00 - 14:20
From chromosome to gene disorder in human spermatogenic failure
Csilla Gabriella Krausz, Italy
14:30 - 14:50
Genetics of teratozoospermia
14:00 - 15:00
Session 56: Patient session:Raising fertility awareness: the importance of informed choices
14:00 - 15:00: Session 56: Patient session:Raising fertility awareness: the importance of informed choices:
Chairperson to be announced
14:00 - 14:15
Fertility literacy in action: design and pilot results from the facts! Serious game in Europe
Mariana Martins, Portugal
14:20 - 14:35
Focus on next generation: promoting informed choices and reproductive health through innovative digital educational platform
14:40 - 14:55
Too young to worry? My fertility journey
14:00 - 15:00
Session 57: Poster discussion session
14:00 - 15:00: Session 57: Poster discussion session:
15:15 - 16:30
Session 58: Advances in IVM, rescue-ICSI, biopsy and embryo selection
15:15 - 16:30: Session 58: Advances in IVM, rescue-ICSI, biopsy and embryo selection:
Chairperson to be announced
Chairperson to be announced
15:15 - 15:30
Trophectoderm biopsy: a comparative analysis of three different techniques on human blastocysts and their impact on apoptosis, necrosis, chromosome analysis and blastocyst recovery
Charlotte Janssens, Belgium
15:30 - 15:45
A comparative analysis of two trophectoderm biopsy protocols employed in preimplantation genetic testing for aneuploidy of blastocysts
Viet Thi Tuan Lai, Vietnam
15:45 - 16:00
Timing matters: assessing the interval between blastocyst expansion and trophectoderm biopsy for live birth outcomes
Asina Bayram, United Arab Emirates
16:00 - 16:15
Evaluating the Role of Rescue IVM and Rescue ICSI in ART: A Systematic Review and Meta-Analysis of Outcomes in Low/Failed Maturation and Fertilisation Cases
Hannah Coffey, United Kingdom
16:15 - 16:30
Variability in conventional AI models for embryo selection: implications for stability and clinical reliability in AI-driven IVF
Manoj Kumar Kanakasabapathy, U.S.A.
15:15 - 16:30
Session 59: Paris on ice: innovations in FET cycles
15:15 - 16:30: Session 59: Paris on ice: innovations in FET cycles:
Christophe Blockeel, Belgium
15:15 - 15:30
Natural ovulation regimen versus programmed regimen for endometrial preparation before frozen embryo transfer (FET) in ovulatory women: a randomized clinical trial
15:30 - 15:45
Natural versus artificial cycle for endometrial preparation in frozen embryo transfer cycles in ovulatory women: a randomized controlled trial
Brecht Geysenbergh, Belgium
15:45 - 16:00
Individualized luteal phase support with intramuscular progesterone in patients with low serum progesterone on the day of frozen-thawed embryo transfer: a randomized clinical trial
Thi Minh Chau Le, Vietnam
16:00 - 16:15
Serum progesterone on day of frozen embryo transfer (FET), including non-rescued patients with low progesterone, does not impact outcome: a prospective analysis and randomized trial
16:15 - 16:30
The live birth rate in Frozen Embryo Transfer (FET) cycles is correlated with the mid-luteal progesterone and estradiol values. A systematic review and meta-analysis.
Angelo Alessandro Marino, Italy
15:15 - 16:30
Session 60: Male health and infertility: two sides of the same coin
15:15 - 16:30: Session 60: Male health and infertility: two sides of the same coin:
Chairperson to be announced
Chairperson to be announced
15:15 - 15:30
Male infertility: is prevention the missing piece?
15:30 - 15:45
Healthy men age without significant decline in reproductive function: insights from the longitudinal FAMe study
15:45 - 16:00
The presence of microplastics in testicular tissue: implications for male infertility
Gevorg Grigoryan, Armenia
16:00 - 16:15
Ultra-processed foods consumption and semen quality parameters among men attending a fertility clinic
16:15 - 16:30
Male infertility and risk of cardiometabolic conditions: a population-based cohort study
15:15 - 16:30
Session 61: Emerging diagnostic and treatment strategies for endometrial conditions and endometriosis
15:15 - 16:30: Session 61: Emerging diagnostic and treatment strategies for endometrial conditions and endometriosis:
Angelos Daniilidis, Greece
15:15 - 15:30
Vipoglanstat, an oral non-hormonal treatment in clinical development for endometriosis
Charlotte Edenius, Sweden
15:30 - 15:45
New Approaches to the Treatment of Chronic Endometritis: Evaluating the Effectiveness of Intrauterine Irrigations with PBMC, G-CSF, Stem Cells.
Vladislava Khalenko, Russia C.I.S.
15:45 - 16:00
Oil-based versus water-based contrast media for hysterosalpingography in infertile women with advanced age, ovulation disorders or high risk of tubal pathology: a randomised controlled trial
Janette Huijser, The Netherlands
16:00 - 16:15
Thin endometrium patients suffer from a higher risk of window of implantation displacement - A propensity score matching study
Diana Valbuena Perilla, Spain
16:15 - 16:30
The association between endometriosis and endometrial polyps: a systematic review and meta-analysis
15:15 - 16:30
Session 62: Age matters: the genetic perspective on reproductive outcomes
15:15 - 16:30: Session 62: Age matters: the genetic perspective on reproductive outcomes:
Helen O'Neill, United Kingdom
Chairperson to be announced
15:15 - 15:30
Epigenetic age and fertility timeline: testing an epigenetic clock to forecast in vitro fertilization success rate
15:30 - 15:45
The effect of maternal ages on the pregnancy outcomes of euploid transfers: a meta-analysis discussing endometrial aging
15:45 - 16:00
Risk of live-born aneuploidy is higher in younger patients, compared to patients of significantly advanced maternal age, a study of PGT-A results for 311,296 embryos
Kristine McWilliams, U.S.A.
16:00 - 16:15
Improved live birth rates and reduced miscarriage rates per single embryo transfer through aneuploidy screening in young patients undergoing PGT-M
Frauke Vanden Meerschaut, Belgium
16:15 - 16:30
Dysregulation of the actin cytoskeleton and FMRP causes oocyte maturation defects in human fragile X premutation and aged oocytes.
Jeannine Gerhardt, U.S.A.
15:15 - 16:30
Session 63: Stem cells and how they model reproductive science
15:15 - 16:30: Session 63: Stem cells and how they model reproductive science:
Chairperson to be announced
15:15 - 15:30
Single-cell multi-omics to study genome plasticity in synthetic models of early human development
Darina Obukhova, The Netherlands
15:30 - 15:45
Replication of male gametes to produce offsprings with a conserved male haplotype
15:45 - 16:00
Administration of umbilical cord blood and placenta in the treatment of chronic endometritis in repeated implantation failures patients
Evgenia Zhylkova, Ukraine
16:00 - 16:15
Human-based placenta-embryoid body chip for developmental toxicity assessment of nanoparticles and drugs
Manon Murdeu, Switzerland
16:15 - 16:30
The effects of Y chromosome genes on mouse ES cells
Kenta Murakami, United Kingdom
15:15 - 16:30
Session 64: Poster discussion session
15:15 - 16:30: Session 64: Poster discussion session:
16:30 - 17:00
Coffee break
16:30 - 17:00: Coffee break:
17:00 - 18:00
Session 65: Cytoplasmic strings and direct cleavage: where are we now?
17:00 - 18:00: Session 65: Cytoplasmic strings and direct cleavage: where are we now?:
Chairperson to be announced
17:00 - 17:15
Developmental significance of cytoplasmic movements within the first 24-72 hours of human preimplantation development: a promising AI-powered assessment to predict blastulation
17:15 - 17:30
Direct cleavage at the 2-cell stage is more prevalent in the blastomere likely to develop into the epiblast: potential implications for embryo selection
17:30 - 17:45
The presence of cytoplasmic strings in human blastocysts is associated with the probability of clinical pregnancy
17:45 - 18:00
Cytoplasmic strings in human in-vitro embryos: a promising indicator for enhanced live-birth outcomes – a systematic review and meta-analysis
Victoria Dodhia, United Kingdom
17:00 - 18:00
Session 66: Is there any light at the end of the POI tunnel?
17:00 - 18:00: Session 66: Is there any light at the end of the POI tunnel?:
Biljana Popovic - Todorovic, Serbia
Chairperson to be announced
17:00 - 17:15
Incidence and factors associated with premature ovarian insufficiency: a population-based cohort study
Jessica MacIntyre, Canada
17:15 - 17:30
Immunomodulatory therapy can restore fertility in women with autoimmune premature ovarian insufficiency – a proof of concept study
Angelica Lindén Hirschberg, Sweden
17:30 - 17:45
Sleep patterns and the incidence of premature ovarian insufficiency: evidence from the UK biobank and NHANES study
17:45 - 18:00
Nicotinamide mononucleotide-a NAD+ precursor- a new hope for rejuvinating fertility outcome in young infertile women with diminished ovarian reserve- a retrospective analysis
Debjani Sen Sharma, India
17:00 - 18:00
Session 67: Old topics and new approaches in implantation and early pregnancy
17:00 - 18:00: Session 67: Old topics and new approaches in implantation and early pregnancy:
Nicola Tempest, United Kingdom
Chairperson to be announced
17:00 - 17:15
Symptoms and signs of adenomyosis according to the revised MUSA criteria in 375 women with pregnancy loss and known ploidy of the pregnancy loss.
Nicolaj Bruun Brandt, Denmark
17:15 - 17:30
Reducing uncertainty in early pregnancy: Using clinical features and radiomics to develop a machine learning model to predict outcome
Sughashini Murugesu, United Kingdom
17:30 - 17:45
Impact of glucagon-like peptide-1 receptor (GLP-1R) agonist therapy on the endometrium and embryo: a boon to infertility?
17:45 - 18:00
Impact of combined treatment by pentoxifylline and tocopherol on endometrial proliferation and vascularization in women with recurrent implantation failure or recurrent pregnancy loss
Laurine Prudhomme, Belgium
17:00 - 18:00
Session 68: Ethical, legal and social dimensions of gamete donation and reproductive rights
17:00 - 18:00: Session 68: Ethical, legal and social dimensions of gamete donation and reproductive rights:
17:00 - 17:15
Identifying essential information for a valid informed consent (IC) of egg donors: An international Delphi study
17:15 - 17:30
Reproductive rights denied in italy: legal discrimination against single women, same-sex couples, transgender individuals, and the global controversy of surrogacy – a comparative perspective
17:30 - 17:45
A Legacy of Hope: egg Donor contributions in shaping the research and clinical translation of mitochondrial donation enabled by ethical, legal and policy change.
Meenakshi Choudhary, United Kingdom
17:45 - 18:00
Disorders or neurodiversity: debating grounds for the restriction of gamete donors
17:00 - 18:00
Session 69: Advances in sperm detection and selection
17:00 - 18:00: Session 69: Advances in sperm detection and selection:
Chairperson to be announced
Chairperson to be announced
17:00 - 17:15
Clinical evaluation of an artificial intelligence (AI) model for rare sperm detection in testis biopsies and azoospermic semen for ICSI
17:15 - 17:30
A comparative study of ai-based automated sperm selection and embryologists: evaluation of sibling oocyte outcomes in intracytoplasmic sperm injection
17:30 - 17:45
T’easy: redefining sperm detection after testicular sperm extraction (TESE) – A faster, smarter and more efficient approach to sperm retrieval in IVF Labs.
17:45 - 18:00
Comparison of reproductive outcomes using density gradient centrifugation, PICSI, and microfluidic sperm sorting in ICSI patients with abnormal DNA fragmentation index
17:00 - 18:00
Session 70: Poster discussion session
17:00 - 18:00: Session 70: Poster discussion session:
18:00 - 19:00
Annual General Assembly
18:00 - 19:00: Annual General Assembly: